Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 7853424, 7 pages
http://dx.doi.org/10.1155/2016/7853424
Research Article

Thrombosis Related ABO, F5, MTHFR, and FGG Gene Polymorphisms in Morbidly Obese Patients

1Department of Anesthesiology, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50009 Kaunas, Lithuania
2Institute for Digestive Research, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50009 Kaunas, Lithuania
3Department of Gastroenterology, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50009 Kaunas, Lithuania
4Department of Surgery, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50009 Kaunas, Lithuania

Received 2 August 2016; Revised 23 October 2016; Accepted 1 November 2016

Academic Editor: Yi-Chia Huang

Copyright © 2016 Kristina Kupcinskiene et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J.-P. Després and I. Lemieux, “Abdominal obesity and metabolic syndrome,” Nature, vol. 444, no. 7121, pp. 881–887, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. E. J. Bell, P. L. Lutsey, S. Basu et al., “Lifetime risk of venous thromboembolism in two cohort studies,” The American Journal of Medicine, vol. 129, no. 3, pp. 339.e19–339.e26, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Saab and S. P. Salvatore, “Evaluating the cause of death in obese individuals: a ten-year medical autopsy study,” Journal of Obesity, vol. 2015, Article ID 695374, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Olié, C. Fuhrman, F. Chin, A. Lamarche-Vadel, P.-Y. Scarabin, and C. de Peretti, “Time trends in pulmonary embolism mortality in France, 2000–2010,” Thrombosis Research, vol. 135, no. 2, pp. 334–338, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. T. Rocha, Â. G. de Vasconcellos, E. R. da Luz Neto, D. M. A. Araújo, E. S. Alves, and A. A. Lopes, “Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery,” Obesity Surgery, vol. 16, no. 12, pp. 1645–1655, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. B. R. Childs, N. J. Nahm, A. J. Dolenc, and H. A. Vallier, “Obesity is associated with more complications and longer hospital stays after orthopaedic trauma,” Journal of Orthopaedic Trauma, vol. 29, no. 11, pp. 504–509, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Marquez-Lara, S. V. Nandyala, S. Sankaranarayanan, M. Noureldin, and K. Singh, “Body mass index as a predictor of complications and mortality after lumbar spine surgery,” Spine, vol. 39, no. 10, pp. 798–804, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. P. L. Lutsey, M. Cushman, S. R. Heckbert, W. Tang, and A. R. Folsom, “Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height. The Longitudinal Study of Thromboembolism Etiology (LITE),” Thrombosis and Haemostasis, vol. 106, no. 1, pp. 113–120, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. L. E. Flinterman, A. van Hylckama Vlieg, F. R. Rosendaal, and S. C. Cannegieter, “Body height, mobility, and risk of first and recurrent venous thrombosis,” Journal of Thrombosis and Haemostasis, vol. 13, no. 4, pp. 548–554, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. Emerging Risk Factors Collaboration, “Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis,” International Journal of Epidemiology, vol. 41, no. 5, pp. 1419–1433, 2012. View at Google Scholar
  11. B. R. Bell, P. E. Bastien, and J. D. Douketis, “Prevention of venous thromboembolism in the Enhanced Recovery After Surgery (ERAS) setting: an evidence-based review,” Canadian Journal of Anesthesia, vol. 62, no. 2, pp. 194–202, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. J. C. A. Souto, G. Pena, A. Ziyatdinov et al., “A genomewide study of body mass index and its genetic correlation with thromboembolic risk. Results from the GAIT project,” Thrombosis and haemostasis, vol. 112, no. 5, pp. 1036–1043, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Samad and W. Ruf, “Inflammation, obesity, and thrombosis,” Blood, vol. 122, no. 20, pp. 3415–3422, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. K. F. Standeven, S. Uitte de Willige, A. M. Carter, and P. J. Grant, “Heritability of clot formation,” Seminars in Thrombosis and Hemostasis, vol. 35, no. 5, pp. 458–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. C. Souto, L. Almasy, M. Borrell et al., “Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia,” The American Journal of Human Genetics, vol. 67, no. 6, pp. 1452–1459, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. D.-A. Trégouët, S. Heath, N. Saut et al., “Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach,” Blood, vol. 113, no. 21, pp. 5298–5303, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Paré, D. I. Chasman, A. N. Parker et al., “Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population: a genome-wide evaluation of 13 974 participants in the Women’s Genome Health Study,” Circulation: Cardiovascular Genetics, vol. 2, no. 2, pp. 142–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Tang, M. Teichert, D. I. Chasman et al., “A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium,” Genetic Epidemiology, vol. 37, no. 5, pp. 512–521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Germain, N. Saut, N. Greliche et al., “Genetics of venous thrombosis: insights from a new genome wide association study,” PLoS ONE, vol. 6, no. 9, Article ID e25581, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. R. Folsom, W. Tang, L.-C. Weng et al., “Replication of a genetic risk score for venous thromboembolism in whites but not in African Americans,” Journal of Thrombosis and Haemostasis, vol. 14, no. 1, pp. 83–88, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Klovaite, M. Benn, and B. G. Nordestgaard, “Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study,” Journal of Internal Medicine, vol. 277, no. 5, pp. 573–584, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Kupcinskas, T. Wex, A. Link et al., “PSCA and MUC1 gene polymorphisms are associated with gastric cancer and pre-malignant gastric conditions [corrected],” Anticancer Research, vol. 34, no. 12, pp. 7167–7175, 2014. View at Google Scholar
  23. J. Kupcinskas, I. Bruzaite, S. Juzenas et al., “Lack of association between miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 gene polymorphisms and colorectal cancer,” Scientific Reports, vol. 4, article 5993, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Purcell, B. Neale, K. Todd-Brown et al., “PLINK: a tool set for whole-genome association and population-based linkage analyses,” The American Journal of Human Genetics, vol. 81, no. 3, pp. 559–575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. P.-E. Morange, P. Suchon, and D.-A. Trégouët, “Genetics of venous thrombosis: update in 2015,” Thrombosis and Haemostasis, vol. 114, no. 5, pp. 910–919, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. N. L. Smith, M.-H. Chen, A. Dehghan et al., “Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor, The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium,” Circulation, vol. 121, no. 12, pp. 1382–1392, 2010. View at Publisher · View at Google Scholar
  27. M. Germain, D. I. Chasman, H. de Haan et al., “Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism,” The American Journal of Human Genetics, vol. 96, no. 4, pp. 532–542, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Bruzelius, M. Bottai, M. Sabater-Lleal et al., “Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors,” Journal of Thrombosis and Haemostasis, vol. 13, no. 2, pp. 219–227, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. F. M. K. Williams, A. M. Carter, P. G. Hysi et al., “Ischemic stroke is associated with the ABO locus: the EuroCLOT study,” Annals of Neurology, vol. 73, no. 1, pp. 16–31, 2013. View at Publisher · View at Google Scholar
  30. Y.-F. Duan, F. Zhu, X.-D. Li et al., “Association between ABO gene polymorphism (rs505922) and cancer risk: a meta-analysis,” Tumor Biology, vol. 36, no. 7, pp. 5081–5087, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Segers, B. Dahlbäck, and G. A. F. Nicolaes, “Coagulation factor V and thrombophilia: background and mechanisms,” Thrombosis and Haemostasis, vol. 98, no. 3, pp. 530–542, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Goyette, J. S. Sumner, R. Milos et al., “Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification,” Nature Genetics, vol. 7, no. 2, pp. 195–200, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. Y.-L. Wu, C.-Y. Hu, S.-S. Lu et al., “Association between methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and essential hypertension: a systematic review and meta-analysis,” Metabolism: Clinical and Experimental, vol. 63, no. 12, pp. 1503–1511, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Rai, “Folate pathway gene MTHFR C677T polymorphism and risk of lung cancer in Asian populations,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 21, pp. 9259–9264, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Abbas, S. T. Raza, F. Ahmed, A. Ahmad, S. Rizvi, and F. Mahdi, “Association of Genetic polymorphism of PPARγ-2, ACE, MTHFR, FABP-2 and FTO genes in risk prediction of type 2 diabetes mellitus,” Journal of Biomedical Science, vol. 20, article 80, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. S.-C. Liew and E. Das Gupta, “Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases,” European Journal of Medical Genetics, vol. 58, no. 1, pp. 1–10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. W.-C. Park and J.-H. Chang, “Clinical implications of methylenetetrahydrofolate reductase mutations and plasma homocysteine levels in patients with thromboembolic occlusion,” Vascular Specialist International, vol. 30, no. 4, pp. 113–119, 2014. View at Publisher · View at Google Scholar
  38. S. U. de Willige, M. C. H. de Visser, J. J. Houwing-Duistermaat, F. R. Rosendaal, H. L. Vos, and R. M. Bertina, “Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen γ′ levels,” Blood, vol. 106, no. 13, pp. 4176–4183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. K. H. Borch, C. Nyegaard, J.-B. Hansen et al., “Joint effects of obesity and body height on the risk of venous thromboembolism: the Tromsø Study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 6, pp. 1439–1444, 2011. View at Publisher · View at Google Scholar · View at Scopus